CIK 0001676725 · Large accelerated filer
IDEAYA Biosciences, Inc.
Sign in to watch- Ticker
- IDYA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 474268251
- Phone
- 650-443-6209
- Business address
- 5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Scientific Officer sold 28,500 shares at an average $36.24 ($1,032,884)
- 4 Planned sale President and CEO sold 175,000 shares at an average $42.27 ($7,397,291)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale See Remarks sold 2,000 shares at $46.02 ($92,045)
- 4 Planned sale President and CEO sold 99,372 shares at an average $45.24 ($4,495,550)
- 4 Planned sale President and CEO sold 628 shares at an average $45.00 ($28,260)
- 4 Planned sale See Remarks sold 2,000 shares at $42.03 ($84,050)
- 4 Planned sale See Remarks sold 2,000 shares at $38.01 ($76,026)
- 4 Planned sale President and CEO sold 75,000 shares at an average $40.15 ($3,010,882)
- 4 Planned sale Chief Legal Officer sold 10,000 shares at $35.04 ($350,371)
- 4 Planned sale President and CEO sold 75,000 shares at $35.03 ($2,627,618)
- 4 Planned sale See Remarks sold 2,000 shares at an average $34.00 ($68,002)
- 4 Planned sale Chief Legal Officer sold 5,163 shares at $30.09 ($155,360)
- 4 Planned sale Chief Legal Officer sold 1,000 shares at an average $30.01 ($30,005)
Page 3 of 10 · 197 filings